232 related articles for article (PubMed ID: 29241325)
21. Application of EPR to porphyrin-protein agents for photodynamic therapy.
Sannikova NE; Timofeev IO; Chubarov AS; Lebedeva NS; Semeikin AS; Kirilyuk IA; Tsentalovich YP; Fedin MV; Bagryanskaya EG; Krumkacheva OA
J Photochem Photobiol B; 2020 Oct; 211():112008. PubMed ID: 32932136
[TBL] [Abstract][Full Text] [Related]
22. Highly Effective Generation of Singlet Oxygen by an Imidazole-Linked Robust Photosensitizing Covalent Organic Framework.
Luan TX; Du L; Wang JR; Li K; Zhang Q; Li PZ; Zhao Y
ACS Nano; 2022 Dec; 16(12):21565-21575. PubMed ID: 36472955
[TBL] [Abstract][Full Text] [Related]
23. Carbon network-hosted porphyrin as a highly biocompatible nanophotosensitizer for enhanced photodynamic therapy.
Wang M; Zheng Y; He H; Lv T; Xu X; Fang X; Lu C; Yang H
Biomater Sci; 2023 Nov; 11(22):7423-7431. PubMed ID: 37815807
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers.
Arnaut LG; Pereira MM; Dąbrowski JM; Silva EF; Schaberle FA; Abreu AR; Rocha LB; Barsan MM; Urbańska K; Stochel G; Brett CM
Chemistry; 2014 Apr; 20(18):5346-57. PubMed ID: 24644142
[TBL] [Abstract][Full Text] [Related]
25. Porphyrin-Based Metal-Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy.
Yu W; Zhen W; Zhang Q; Li Y; Luo H; He J; Liu Y
ChemMedChem; 2020 Oct; 15(19):1766-1775. PubMed ID: 32715651
[TBL] [Abstract][Full Text] [Related]
26. Incorporation of Porphyrin to π-Conjugated Backbone for Polymer-Dot-Sensitized Photodynamic Therapy.
Chang K; Tang Y; Fang X; Yin S; Xu H; Wu C
Biomacromolecules; 2016 Jun; 17(6):2128-36. PubMed ID: 27219282
[TBL] [Abstract][Full Text] [Related]
27. Unleashing the power of porphyrin photosensitizers: Illuminating breakthroughs in photodynamic therapy.
Akbar A; Khan S; Chatterjee T; Ghosh M
J Photochem Photobiol B; 2023 Nov; 248():112796. PubMed ID: 37804542
[TBL] [Abstract][Full Text] [Related]
28. Self-Assembly of Monomeric Hydrophobic Photosensitizers with Short Peptides Forming Photodynamic Nanoparticles with Real-Time Tracking Property and without the Need of Release in Vivo.
Li J; Wang A; Zhao L; Dong Q; Wang M; Xu H; Yan X; Bai S
ACS Appl Mater Interfaces; 2018 Aug; 10(34):28420-28427. PubMed ID: 30067331
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic Therapy Based on Nanoscale Metal-Organic Frameworks: From Material Design to Cancer Nanotherapeutics.
Guan Q; Li YA; Li WY; Dong YB
Chem Asian J; 2018 Nov; 13(21):3122-3149. PubMed ID: 30183134
[TBL] [Abstract][Full Text] [Related]
30. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.
Jin CS; Cui L; Wang F; Chen J; Zheng G
Adv Healthc Mater; 2014 Aug; 3(8):1240-9. PubMed ID: 24464930
[TBL] [Abstract][Full Text] [Related]
31. The bromoporphyrins as promising anti-tumor photosensitizers in vitro.
Li MY; Mi L; Namulinda T; Yan YJ; Zhou XP; Chen ZL
Photochem Photobiol Sci; 2023 Feb; 22(2):427-439. PubMed ID: 36344865
[TBL] [Abstract][Full Text] [Related]
32. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
33. A Highly Efficient and Photostable Photosensitizer with Near-Infrared Aggregation-Induced Emission for Image-Guided Photodynamic Anticancer Therapy.
Wu W; Mao D; Hu F; Xu S; Chen C; Zhang CJ; Cheng X; Yuan Y; Ding D; Kong D; Liu B
Adv Mater; 2017 Sep; 29(33):. PubMed ID: 28671732
[TBL] [Abstract][Full Text] [Related]
34. Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer.
Nguyen VN; Yan Y; Zhao J; Yoon J
Acc Chem Res; 2021 Jan; 54(1):207-220. PubMed ID: 33289536
[TBL] [Abstract][Full Text] [Related]
35. Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers.
Tian Z; Li H; Liu Z; Yang L; Zhang C; He J; Ai W; Liu Y
Curr Treat Options Oncol; 2023 Sep; 24(9):1274-1292. PubMed ID: 37407889
[TBL] [Abstract][Full Text] [Related]
36. Protein-protected gold/silver alloy nanoclusters in metal-enhanced singlet oxygen generation and their correlation with photoluminescence.
Yu Y; Lee WD; Tan YN
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110525. PubMed ID: 32228897
[TBL] [Abstract][Full Text] [Related]
37. Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging.
Loman-Cortes P; Binte Huq T; Vivero-Escoto JL
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770861
[TBL] [Abstract][Full Text] [Related]
38. Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties.
Stallivieri A; Colombeau L; Jetpisbayeva G; Moussaron A; Myrzakhmetov B; Arnoux P; Acherar S; Vanderesse R; Frochot C
Bioorg Med Chem; 2017 Jan; 25(1):1-10. PubMed ID: 27769669
[TBL] [Abstract][Full Text] [Related]
39. A new nonconjugated naphthalene derivative of meso-tetra-(3-hydroxy)-phenyl-porphyrin as a potential sensitizer for photodynamic therapy.
Silva P; Fonseca SM; Arranja CT; Burrows HD; Urbano AM; Sobral AJ
Photochem Photobiol; 2010; 86(5):1147-53. PubMed ID: 20553404
[TBL] [Abstract][Full Text] [Related]
40. Plasmon-Accelerated Generation of Singlet Oxygen on an Au/MoS
Younis MR; An R; Wang Y; He G; Gurram B; Wang S; Lin J; Ye D; Huang P; Xia XH
ACS Appl Bio Mater; 2022 Feb; 5(2):747-760. PubMed ID: 35040617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
